Mimedx Group Inc (MDXG) Directors and Executive Officers - CSIMarket
CSIMarket
 
Mimedx Group Inc   (NASDAQ: MDXG)

Mimedx Group Inc

Officers & Directors


M. Kathleen Behrens
Chair of the Board - (Director)

Cato T. Laurencin
Director -

Martin P. Sutter
Director -

Doug Rice
Chief Financial Officer -

Michael J. Giuliani
Director -

William A. Hawkins III
Director -

Doug Rice
Chief Financial Officer

Joseph H. Capper
Chief Executive Officer and Director -

Phyllis I. Gardner
Director -

James L. Bierman
Director -

K. Todd Newton
Director - ,

Mimedx Group Inc currently has 808 employees.

  News about Mimedx Group Inc Key Personnel

MIMEDX: A Vanguard of Change in Healthcare Costs and Wound Care Innovation,

MIMEDX s Strategic Advocacy and Innovative Developments: A New Era in Wound Care and Medicare Cost ManagementIn recent months, MIMEDX Group Inc has made significant strides in both advocating for cost-effective healthcare practices and innovating within the realm of regenerative medicine. This dual focus not only reflects the company s commitment to the healthcare sector but also serves as a response to the overwhelming costs associated with unproven medical treatments. Notably, MIMEDX s efforts to reining in the rampant spending associated with Medicare coverage for skin substitutes have begun to show promising results, marking a pivotal moment for the company and the healthcare industry at large. Effectiv...






MDXG Management Effectiveness MDXG Revenue per Employee MDXG Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.